Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCHEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCHECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCHECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCHEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCHEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JF.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JF.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JF.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used